1,473
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis

, , & ORCID Icon
Pages 8347-8357 | Received 08 Sep 2021, Accepted 24 Sep 2021, Published online: 19 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Dong Wei, Jing Zeng, Feng Rong, Yasheng Xu, Rong Wei & Can Zou. (2022) Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5). Bioengineered 13:3, pages 5126-5140.
Read now
Xuemei Liu, Zhiping Yin, Yanjun Wu, Qian Zhan, Honghong Huang & Jiangtao Fan. (2022) Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer. Bioengineered 13:2, pages 3739-3750.
Read now
Shijie Wu, Ting Luo, Xiaoyong Lei & Xiaoyan Yang. Emerging role of competing endogenous RNA in lung cancer drug resistance. Journal of Chemotherapy 0:0, pages 1-20.
Read now

Articles from other publishers (8)

Maliheh Entezari, Mahshid Deldar Abad Paskeh, Sima Orouei, Amirabbas Kakavand, Shamin Rezaei, Elahe Sadat Hejazi, Parya Pashootan, Naghmeh Nazdari, Alireza Tavakolpournegari, Mehrdad Hashemi, Shokooh Salimimoghadam, Sepideh Mirzaei, Afshin Taheriazam & Saeed Samarghandian. (2024) Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance. Current Cancer Drug Targets 24:1, pages 94-113.
Crossref
Shaofeng Xia & Chenliang Wang. (2023) Hsa_circ_0003220 Drives Chemoresistance of Human NSCLC Cells by Modulating miR-489-3p/IGF1. International Journal of Genomics 2023, pages 1-12.
Crossref
Anmol Bhatia, Atul Kumar Upadhyay & Siddharth Sharma. (2022) miRNAs are now starring in “ No Time to Die : Overcoming the chemoresistance in cancer” . IUBMB Life 75:3, pages 238-256.
Crossref
Qian Yi, Jianguo Feng, Yi Liao & Weichao Sun. (2022) Circular RNAs in chemotherapy resistance of lung cancer and their potential therapeutic application . IUBMB Life 75:3, pages 225-237.
Crossref
Zixin Zhu, Hui Jiang, Jingling Xie, Xinrui Jin, Baolin Li & Jinbo Liu. (2022) Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis. Scientific Reports 12:1.
Crossref
Fei Gao, Jianjun Han, Li Jia, Jun He, Yun Wang & Mi Chen. (2022) CircCEP85 upregulates IGF1 expression to promote breast cancer progression via sponging miR-1193. Applied Biological Chemistry 65:1.
Crossref
Roberto Cuttano, Miriam Kuku Afanga & Fabrizio Bianchi. (2022) MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going. Cancers 14:23, pages 5731.
Crossref
Tinghao Yan, Xinchen Tian, Fen Liu, Qingbin Liu, Qing Sheng, Jianlin Wu & Shulong Jiang. (2022) The emerging role of circular RNAs in drug resistance of non-small cell lung cancer. Frontiers in Oncology 12.
Crossref